Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
19 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurophth-announces-completion-of-patient-enrollment-for-opvika-phase-iii-clinical-trial-in-the-us-302064859.html
17 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurophth-announces-first-patient-dosed-in-phase-iii-clinical-trial-of-second-gene-therapy-301903288.html
14 Aug 2023
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2023-08-14/neurophth-secures-95m-in-series-c-financing-for-gene-therapy-clinical-trials/?widget=listSection
21 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/commercialization-of-gene-therapy-is-coming-soon-neurophth-completes-patient-enrollment-for-phase-iii-clinical-trial-for-the-gene-therapy-treatment-of-lhon-301751494.html
19 Dec 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/neurophth-receives-ind-clearance-from-fda-for-aav-nd1-gene-therapy-of-lhon-301705927.html
08 Nov 2022
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/cyagen-neurophth-gene-therapy/
ABOUT THIS PAGE